Invesco
JBIO

Invesco’s Jade Biosciences JBIO Stock Holding History

Invesco’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$403K Sell
18,119
-11,441
-39% -$239K ﹤0.01% 3326
2026
Q1 		$415K Sell
29,560
-170,167
-85% -$2.46M ﹤0.01% 3227
2025
Q4 		$3.08M Buy
199,727
+165,151
+478% +$1.94M ﹤0.01% 2440
2025
Q3 		$298K Buy
+34,576
New +$283K ﹤0.01% 3420
2025
Q2 		– Sell
-2,127
Closed -$187K – 3772
2025
Q1 		$187K Buy
+2,127
New +$187K ﹤0.01% 3526
2023
Q1 		– Sell
-2,074
Closed -$2.13M – 3872
2022
Q4 		$2.13M Buy
+2,074
New +$1.51M ﹤0.01% 2625

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco's JBIO Position: Q2 2026 in Review

Invesco reduced its Jade Biosciences (JBIO) stake by 39% in Q2 2026, selling an estimated $239K and leaving 18,119 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #3326.

Invesco first reported a position in JBIO in Q4 2022 and has held it in 6 quarters since. The position peaked at $3.08M in Q4 2025. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Invesco held 18,119 shares of Jade Biosciences worth $403K as of Q2 2026.
  • Invesco sold 11,441 Jade Biosciences shares in Q2 2026, an estimated $239K.
  • Jade Biosciences made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3326 holding.
  • Invesco first reported a position in Jade Biosciences in Q4 2022 and has held it in 6 quarters since.
  • Invesco's Jade Biosciences position peaked at $3.08M in Q4 2025.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.